Natriuretic peptide [NP; B‐type NP (BNP), N‐terminal proBNP (NT‐proBNP), and
midregional proANP (MR‐proANP)] concentrations are quantitative plasma biomarkers for …

Acute heart failure (AHF) is a syndrome defined as the new onset (de novo heart failure
(HF)) or worsening (acutely decompensated heart failure (ADHF)) of symptoms and signs of …

Serum biomarkers are an important tool in the baseline risk assessment and diagnosis of
cardiovascular disease in cancer patients receiving cardiotoxic cancer treatments. Increases …

A organização de uma diretriz clínica é tarefa complexa, que necessariamente deve
envolver planejamento prévio, coordenação apropriada, revisão aprofundada da literatura …

2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American
College of Cardiology Foundation/American Heart Association Task Force on Practice …

Background Acute heart failure (AHF) is one of the most common diagnoses assigned to
emergency department (ED) patients who are hospitalized. Despite its high prevalence in …

Background: Identification of systolic heart failure among patients presenting to the
emergency department (ED) with acute dyspnea is challenging. The reasons for dyspnea …

Many advances have been made in the diagnosis and management of heart failure (HF) in
recent years. Cardiac biomarkers are an essential tool for clinicians: point of care B-type …

BACKGROUND Lung ultrasonography (LUS) has emerged as a noninvasive tool for the
differential diagnosis of pulmonary diseases. However, its use for the diagnosis of acute …

A consensus conference on cardio-renal syndromes (CRS) was held in Venice Italy, in
September 2008 under the auspices of the Acute Dialysis Quality Initiative (ADQI). The …